Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 09 Apr 2025 15:19 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associates of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 09 Apr 2025 08:13 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA | 20103010 Biotechnology | Flagging |
| 04 Apr 2025 10:52 CEST |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associates of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Apr 2025 08:38 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Notice of Annual General Meeting on 24 April 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA publishes Annual report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Mar 2025 16:46 CET |
THOR MEDICAL ASA | Thor Medical makes final investment decision for AlphaOne - ready for commercial production in 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Feb 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA interim and full-year 2024 results - closing in on commercial launch | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 20 Feb 2025 08:00 CET |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's second half and full year results 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Feb 2025 09:25 CET |
THOR MEDICAL ASA | Thor Medical ASA: Share capital increase in relation to Subsequent Offering registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 24 Jan 2025 20:17 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Jan 2025 20:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Final results of the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jan 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: The Subscription Period in the Subsequent Offering ends today at 12:30 CET | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Jan 2025 16:27 CET |
THOR MEDICAL ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Jan 2025 14:01 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Meldepliktig handel for primærinnsidere |
| 15 Jan 2025 11:01 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholdings | 20103010 Biotechnology | Flagging |
| 15 Jan 2025 10:31 CET |
THOR MEDICAL ASA | Thor Medical ASA: Share capital increase in relation to Tranche 2 of the Private Placement is registered | 20103010 Biotechnology | Changes in the rights attaching to the classes of shares or securities |
| 13 Jan 2025 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Commencement of the subscription period for the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Jan 2025 13:30 CET |
THOR MEDICAL ASA | Thor Medical ASA: Approval of prospectus and launch of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Jan 2025 07:45 CET |
THOR MEDICAL ASA | Thor Medical secures NOK 90 million loan from Innovation Norway, ensuring full financing of AlphaOne | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Jan 2025 15:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding - share lending | 20103010 Biotechnology | Flagging |
| 06 Jan 2025 14:57 CET |
THOR MEDICAL ASA | Thor Medical ASA: Completion of extraordinary general meeting | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 20 Dec 2024 15:06 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 20 Dec 2024 14:26 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 20 Dec 2024 14:23 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholdings and notification of transaction by close associates of primary insiders | 20103010 Biotechnology | Major shareholding notifications |
| 20 Dec 2024 14:17 CET |
THOR MEDICAL ASA | Thor Medical ASA - Share capital increase in relation to Tranche 1 of the Private Placement and the PrimaryBid Offering is registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 19 Dec 2024 07:45 CET |
THOR MEDICAL ASA | Thor Medical and AdvanCell sign strategic supply agreement for Thorium-228 | 20103010 Biotechnology | Inside information |
| 16 Dec 2024 20:34 CET |
THOR MEDICAL ASA | Thor Medical ASA - Notice of Extraordinary General Meeting on 6 January 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Ex. right to participate in subsequent offering today | 20103010 Biotechnology | Ex Date |
| 12 Dec 2024 00:59 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding - share lending | 20103010 Biotechnology | Major shareholding notifications |
| 12 Dec 2024 00:55 CET |
THOR MEDICAL ASA | Thor Medical ASA: Allocation of shares to primary insiders and their close associates in the Private Placement | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 12 Dec 2024 00:43 CET |
THOR MEDICAL ASA | Thor Medical ASA: Key information relating to potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 00:31 CET |
THOR MEDICAL ASA | Thor Medical ASA: Private placement successfully completed | 20103010 Biotechnology | Inside information |
| 11 Dec 2024 16:30 CET |
THOR MEDICAL ASA | Thor Medical ASA: Contemplated private placement and retail offer via PrimaryBid | 20103010 Biotechnology | Inside information |
| 25 Nov 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical capital markets update: Enabling next-generation precision cancer treatments | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Nov 2024 07:45 CET |
THOR MEDICAL ASA | Thor Medical signs agreement for supply of Pb-212 for pre-clinical use with globally leading pharmaceutical company | 20103010 Biotechnology | Inside information |
| 20 Nov 2024 07:30 CET |
THOR MEDICAL ASA | Reminder: Thor Medical invitation to capital markets update 25 November 2024 | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 19 Nov 2024 07:30 CET |
THOR MEDICAL ASA | Thor Medical ships first product sample to potential customer from Herøya pilot facilities | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Nov 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical invitation to capital markets update | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Oct 2024 07:30 CET |
THOR MEDICAL ASA | Thor Medical and ARTBIO sign strategic long-term supply agreement for Thorium-228 | 20103010 Biotechnology | Inside information |
| 30 Sep 2024 21:34 CEST |
THOR MEDICAL ASA | Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 26 Sep 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical completes Herøya pilot facilities and initiates commissioning | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Aug 2024 07:00 CEST |
THOR MEDICAL ASA | Thor Medical ASA reports first half 2024 results - Pilot facility progressing as planned and targeting 'fast-track' scale-up to commercial production | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2024 07:00 CEST |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's first half results 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Aug 2024 18:32 CEST |
THOR MEDICAL ASA | Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 01 Aug 2024 07:30 CEST |
THOR MEDICAL ASA | Jasper Kurth has assumed the position as CEO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jun 2024 07:30 CEST |
THOR MEDICAL ASA | Thor Medical receives DSA authorization for production of alpha-emitters at Herøya pilot plant | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jun 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical releases updated investor presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Jun 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical signs Memorandum of Understanding for feedstock supply and technology cooperation | 20103010 Biotechnology | Non-regulatory press releases |
| 06 May 2024 15:05 CEST |
THOR MEDICAL ASA | Primary insider trading | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 May 2024 13:59 CEST |
THOR MEDICAL ASA | New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |